If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Acta Anaesthesiologica ScandinavicaVolume 43 Issue 9, Pages 918 - 923 Published Online: 29 Apr 2003 Journal compilation © 2010 The Acta Anaesthesiologica Scandinavica Foundation Official Publication of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
Abstract | Full Text: PDF (Size: 113K) | Related Articles | Citation Tracking Opioid rotation in chronic non-malignant pain patients A retrospective study Copyright © Munksgaard 1999 KEYWORDS Opioid rotation • chronic non-malignant pain • side-effects ABSTRACTBackground: The clinical advantage of opioid rotation is probably due to incomplete cross-tolerance favouring analgesia more than adverse effects. The objectives of opioid rotation in chronic non-malignant patients are 1): rotation between different long-acting opioids (LAO) to improve analgesia and reduce side-effects, and 2): rotation from short-acting opioids (SAO) to LAO to establish stable analgesia in order to minimise withdrawal symptoms, risk of tolerance and addiction. Methods: A retrospective analysis of 37 rotations between different LAO and 59 rotations from SAO to LAO. Results: The main reason for opioid rotation was insufficient pain relief. Opioid rotations resulted in significantly better pain control in 59% (CI Conclusion: Opioid rotations between different LAO resulted in better pain control and fewer side-effects at dose levels predicted to be equianalgesic. The majority of the patients rotated from SAO to LAO obtained improved analgesia, but the cost was a 74% increase in the opioid dose. |